-
Most Popular
![Biotech Stocks Icon](https://investorplace.com/wp-content/uploads/2022/12/biotech-150x150.png)
Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.
![The words "recession proof" written on a pink sticky note. bulletproof stocks](https://investorplace.com/wp-content/uploads/2023/07/shutterstock_2170602547-150x150.jpg)
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
![Biochemical/biotech research scientist team working with microscope](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715-150x150.png)
3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.
![Nurse holding a tablet with icons representing different aspects of healthcare and healthcare data representing CANO stock. Healthcare Tech Stocks. Healthcare Stocks to Buy](https://investorplace.com/wp-content/uploads/2022/07/healthcare-1600-150x150.jpg)
The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Recent Biotech Stocks Articles
ALT Stock Alert: Altimmune Pops on Weight-Loss Drug Findings
Altimmune (ALT) stock is soaring and trending after the company reported data on its GLP-1 weight-loss drug today.
The Next Big Thing After AI? 3 Sleeper Stocks to Buy Before the Boom
These three sleeper stocks could deliver massive gains if their cutting-edge technologies take off in the coming years.
Alnylam (ALNY) Stock Soars 30% on Heart Disease Drug Success
The challenge for Alnylam now will be to find and diagnose patients with the condition known as ATTR-CM, which is considered rare.
Ginkgo Bioworks Layoffs 2024: What to Know About the Latest DNA Job Cuts
Ginkgo Bioworks layoffs are a hot topic as the company prepares to cut 158 jobs this week with more headcount reductions coming next week.
Why Is G1 Therapeutics (GTHX) Stock Down 56% Today?
G1 Therapeutics stock is down on Monday as GTHX investors react to the company's Phase 3 clinical trial of trilaciclib failing.
Why Is DermTech (DMTK) Stock Down 26% Today?
DermTech stock is down on Monday as investors prepare for shares of DMTK to be delisted from the Nasdaq Exchange later this week.
7 A-Rated Penny Stocks to Beat June Gloom
Some penny stocks can be diamonds in the rough. These A-rated penny stocks are all solid picks for a portfolio this month.
7 Top Stocks Under $10: June 2024 Edition
While blue chip stocks are great, it's also a good idea to invest in top stocks under $10 to help improve your portfolio's diversification.
3 Biotech Stocks to Buy Now: June 2024
These are the three best biotech stocks to buy for long-term returns and portfolio stability due to their target patient populations,
Sarepta Therapeutics (SRPT) Stock Surges 30% on Giant FDA Boost
How much Sarepta can hope to earn from Elevidys is unclear due to its cost, $3 million, and that it's not a cure. Yet SRPT stock is surging.
Defying the Norms: 3 High P/E Stocks With Room to Run
Gilead Sciences, Crowdstrike and DataDog might be the best high P/E stocks to buy, offering substantial growth despite elevated valuations.
7 F-Rated Penny Stocks to Avoid This June
There are risks associated with any investment – there’s no such thing as a surefire investment, although tools like the Portfolio Grader can make your…
7 Penny Stocks to Turn $3 Into $1 Million Within 36 Months
Wise investors consider penny stocks to buy which represent companies with vigorous fundamentals and a robust growth outlook.
PLTR Stock: Palantir Bags New Partnership With ARPA-H for AI/ML
Palantir stock is on the rise Thursday as PLTR investors react to a new $19 million contract for the big data and AI company.
Why Is NLS Pharmaceutics (NLSP) Stock Down 23% Today?
NLS Pharmaceutics stock is down on Thursday as shares of NLSP come off of a recent rally that was fueled by heavy trading on Tuesday.
Why Is Avrobio (AVRO) Stock Moving Today?
Avrobio stock is in the news Thursday as the company prepares for a merger and reverse stock split of AVRO after markets close today.
Why Is Tempest Therapeutics (TPST) Stock Up 45% Today?
Tempest Therapeutics stock is up on Thursday with heavy trading of TPST shares ahead of a presentation taking place this morning.